Jiajie Biomedical's consolidated revenue in October was NT$38.97 million, a 14% year-on-year increase.

Jiajie Biotech Co., Ltd. (hereinafter referred to as "Jiajie Biotech", stock code 4109), a leading brand of turtle nutritional health products under the Taiwan Steel Group, announced today (10th) that its revenue in October was NT$38.97 million, an increase of 14% year-on-year. The cumulative revenue in October was NT$390.44 million, a decrease of 11% year-on-year.

Jiajie Biomedical stated that as it moves into the fourth quarter, in addition to continuing to consolidate its existing distribution channels, after reviewing its annual operating strategy, it will actively deploy regional physical channel partnerships to increase product market penetration and brand visibility. At the same time, it will also focus on recruiting and allocating professional talent, hoping to comprehensively improve overall operational momentum and maintain a cautiously optimistic outlook on future operating performance.

In addition, to celebrate the Double 11 shopping frenzy, Jiajie Biomedical's e-commerce platform is launching a "Double 11 Shopping Festival" promotion. Not only are all products on the platform discounted by as much as 66%, but customers also enjoy free shipping to their homes regardless of the amount spent. This promotion runs from now until November 16th. For more details on the deals and product information, please visit Jiajie Biomedical's e-commerce platform at https://www.jiajie-mit.com/ or contact customer service at 0800-530-885.

Jiajie Biomedical's Revenue Summary for October 2025: Unit: NT$1,000, %

year During	2025	2024	Annual growth rate
October	38,965	34,320	13.53
January to October	390,443	441,045	-11.47